NCT06652204Recruiting
Validation of the French Version of the QASCI in Caregivers of Patients With COPD
Validation of the French Version of the Informal Caregiver Burden Assessment Questionnaire (QASCI) in Caregivers of Patients With COPD (VALQASCI)
Source: ClinicalTrials.gov · Last updated 16 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to validate the French version of the QASCI questionnaire, initially written and validated in Portuguese language by Hipolito et al., to assess caregiving burden in chronic obstructive pulmonary disease (COPD). The realization of this validation is significant on several levels. First, since COPD is a systemic condition, it affects not only the lungs but also many other organs and systems in the body. It leads to various complications that go beyond respiratory symptoms, creating major challenges not only physically but also in terms of participation and involvement for patients and their caregivers. The lack of validated tools in French to specifically assess the quality of life of caregivers in this context represents a gap that this study seeks to fill. This study is also justified by the fact that, although the QASCI has been validated in other languages and contexts, it is essential to linguistically and culturally adapt this tool for the French-speaking population. Validation in French is crucial to ensure the fidelity of the results obtained and the validity of the conclusions drawn from this instrument for caregivers of patients with COPD in France. In summary, this study addresses a specific need by contributing to the prevention of pathologies among caregivers. It enhances early detection and support for caregivers of patients with COPD while paving the way for future research on this often-overlooked population.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 224 (estimated)
- First submitted
- 15 Oct 2024
- Start date
- 22 Oct 2024
- Primary completion date
- 15 Jun 2026
- Lead sponsor
- University Hospital, Brest
- Diseases
- COPD
- NCT number
- NCT06652204
What you commit to
- Study type: Observational
- Planned participants: 224
- From 22 Oct 2024 to the primary completion date, 15 Jun 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Being a caregiver of a relative with COPD (according to the GOLD criteria).
- Being 18 years old or older.
- The patient under the caregiver's care must be in stable condition (no exacerbations in the previous month).
- Being a family member of the patient or living with the patient.
- Being able to complete the French questionnaires.
- Non-opposition statement provided.
- NON-INCLUSION CRITERIA
- Person under judicial protection (guardianship, curatorship, etc.)
- Refusal to participate
- The patient under the caregiver's care has experienced an exacerbation in the previous month
- The caregiver reports that the patient has cognitive impairments.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chu Brest Coordinator of this site? Confirm its status | Brest | France | Recruiting |
| Centre Hospitalier de Morlaix Coordinator of this site? Confirm its status | Morlaix | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.